Central and peripheral effects of asymmetric dimethylarginine, an endogenous nitric oxide synthetase inhibitor

Journal of Cardiovascular Pharmacology

Volumn 28, Issue 3, 1996, Pages 439-446

  Jin, Jong Shiaw ^a   D'Alecy, Louis G ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Intracerebroventricular; l Arginine; Nitric oxide; Nitric oxide synthetase; Vascular smooth muscle

Indexed keywords

ACETYLCHOLINE; ARGININE; ARGININE DERIVATIVE; DIMETHYLARGININE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; PHENYLEPHRINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AORTA MEDIA; ARTICLE; CARDIOVASCULAR FUNCTION; CONTROLLED STUDY; DOSE RESPONSE; DRUG MECHANISM; HEART RATE; HYPERTENSION; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PRESSORECEPTOR REFLEX; PRIORITY JOURNAL; RAT; VASCULAR ENDOTHELIUM;

ANIMALS; AORTA; ARGININE; BAROREFLEX; DOSE-RESPONSE RELATIONSHIP, DRUG; HEMODYNAMIC PROCESSES; INJECTIONS, INTRAVENOUS; INJECTIONS, INTRAVENTRICULAR; MALE; MUSCLE RELAXATION; MUSCLE, SMOOTH, VASCULAR; NITRIC OXIDE SYNTHASE; NITROARGININE; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0029795806     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199609000-00014     Document Type: Article

References (28)

1. Harada S, Tokunaga S, Momohara M, et al. Inhibition of nitric oxide formation in the nucleus tractus solitarius increases renal sympathetic nerve activity in rabbits, Circ Res 1993;72:511-6.
2. Kimura M, Dietrich HH, Dacey RG. Nitric oxide regulates cerebral arteriolar tone in rats. Stroke 1994;25:2227-34.
3. Togashi H, Sakuma I, Yoshioka M, et al. A central nervous system action of nitric oxide in blood pressure regulation. J Pharmacol Exp Ther 1992;262:343-7.
4. Johnson R A, Freeman RH. Sustained hypertension in the rat induced by chronic blockade of nitric oxide production. Am J Hypertens 1992;5:919-22.
5. da Silva SV, da Silva VJD, Ballejo G, Salgado MCO, Salgado HC. Blockers of the L-arginine-nitric oxide-cyclic GMP pathway facilitate baroreceptor resetting. Hypertension 1994;23(suppl 1):160-3.
6. ω-nitro-L-arginine methyl ester treatment in conscious rats. Hypertension 1994;23:982-6.
7. Vallance P, Leone A, Calver A, Collier J, Moncada S. Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure. Lancet 1992;339:572-5.
8. Vallance P, Leone A, Calver A, Collier J, Moncada S. Endogenous dimethylarginine as an inhibitor of nitric oxide synthesis. J Cardiovasc Pharmacol 1992;20(suppl 12): S60-2.
9. Calver A, Collier J, Leone A, Moncada S, Vallance P. Effect of local intra-arterial asymmetric dimethylarginine (ADMA) on the forearm arteriolar bed of healthy volunteers. J Hum Hypertens 1993;7:193-1.
10. Lou MF. Human muscular dystrophy: elevation of urinary dimethylarginines. Science 1979;203:668-70.
11. ω-dimethylarginine in the urine of patients with muscular dystrophy. Metabolism 1979;28:801-4.
12. Yu X, Li Y, Xiong Y. Increase of an endogenous inhibitor of nitric oxide synthesis in serum of high cholesterol fed rabbits. Life Sci 1994;54:753-8.
13. Fickling SA, Williams D, Vallance P, Nussey SS, Whitley GSJ. Plasma concentrations of endogenous inhibitor of nitric oxide synthesis in normal pregnancy and pre-eclampsia. Lancet 1993;342:242-3.
14. Yudkoff M, Nissim I, Pereira G, Segal S. Urinary excretion of dimethylarginines in premature infants. Biochem Med 1984;32:242-51.
15. Miyake M, Kakimoto Y. Protein methylation by cerebral tissue. J Neurochem 1973;20:859-71.
16. Paik WK, Kim S. Protein methylation in rat brain in vitro. J Neurochem 1969;16:1257-61.
17. Lou MF, Chang AC, Mahoney MJ. Dimethylarginines in human amniotic fluid. Clin Chem 1982;28:553-4.
18. ω-dimethylarginine in rats. Arch Biochem Biophys 1987;252:526-37.
19. ω-dimethylarginine from the hydrolysate of proteins of bovine brain. Biochim Biophys Acta 1971;230:212-2.
20. ωdimethylarginine in the rabbit. Biochem J 1976;154:179-84.
21. Gruetter CA, Grueller DY, Lyon JE, Kadowitz PJ, Ignarro LJ. Relationship between cyclic guanosine 3′:5′-monophosphate formation and relaxation of coronary arterial smooth muscle by glyceryl trinitrate, nitroprusside, nitrite and nitric oxide: effects of methylene blue and methemoglobin. J Pharmacol Exp Ther 1981;219:181-6.
22. Coleman TG. Arterial baroreflex control of heart rate in the conscious rat. Am J Physiol 1980;238:H515-20.
23. Jover B, Herizi A, Ventre F, Dupont M, Mimran A. Sodium and angiotensin in hypertension induced by long-term nitric oxide blockade. Hypertension 1993;21-944-8.
24. ω-dimethylarginine dimethylamino-hydrolase, from rat kidney. J Biol Chem 1989;264:10205-9.
25. Lamas S, Marsden PA, Li GK, Tempst P, Michel T. Endothelial nitric oxide synthase: molecular cloning and characterization of a distinct constitutive enzyme isoform. Proc Natl Acad Sci USA 1992;89:6348-52.
26. Ignarro LJ, Buga GM, Wood KS, Byrns RE, Chaudhuri G. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci USA 1987;84:9265-9.
27. Ignarro LJ, Byrns RE, Buga GM, Wood KS, Chaudhuri G. Pharmacological evidence that endothelium-derived relaxing factor is nitric oxide: use of pyrogallol and Superoxide dismutase to study endothelium-dependent and nitric oxideelicited vascular smooth muscle relaxation. J Pharmacol Exp Ther 1988;244:181-9.
28. Furchgott RF, Cherry PD, Zawadzki JV, Jothianandan D. Endothelial cells as mediators of vasodilation of arteries. J Cardiovasc Pharmacol 1984;6(suppl 2):S336-43.